Bioequivalence for highly variable drugs: regulatory agreements, disagreements, and harmonization
Crossref DOI link: https://doi.org/10.1007/s10928-019-09623-w
Published Online: 2019-02-23
Published Print: 2019-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Endrenyi, Laszlo http://orcid.org/0000-0002-1321-4214
Tothfalusi, Laszlo
Text and Data Mining valid from 2019-02-23
Article History
Received: 18 September 2018
Accepted: 12 February 2019
First Online: 23 February 2019